We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Family Medicine & Nutrition

How Often Should Men Have Sex? Harvard Study Links 21 Times a Month to Lower Prostate Cancer Risk

MedXY Editorial Team•Oct 8, 2025•Family Medicine & Nutrition
cancer preventionejaculation frequencyHarvard studymen's healthprostate cancer

Introduction: The Growing Burden of Prostate Cancer

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in men worldwide, accounting for approximately 15% of all new male cancer cases. As the global burden of prostate cancer continues to increase, identifying effective preventive measures has become a pressing challenge. While diet and physical activity have demonstrated some promise in secondary prevention, there remain no clear evidence-based guidelines specifically advising healthy adult men on how to reduce their risk of developing prostate cancer.

Among the few known risk factors for PCa—such as age, race, family history, and inherited genetic variations—none are modifiable. Therefore, attention has turned to potential lifestyle factors that men can change. One such factor is sexual activity, specifically ejaculation frequency, which has been hypothesized to influence prostate cancer risk through a variety of biological mechanisms.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Specialist Cardiovascular Referral Enhances Cholesterol Management in Prostate Cancer Patients: Insights from a Global Randomized TrialA randomized clinical trial demonstrates that routine cardiovascular specialist referral for prostate cancer patients improves cholesterol control but does not reduce major cardiovascular events over nearly 6 years.Sep 1, 2026Metabolic Dysfunction Following Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer: Clinical Implications and RisksThis study reveals a significant early onset of metabolic syndrome in men with prostate cancer treated with combined ADT and ARPI therapies, highlighting the necessity for multidisciplinary metabolic monitoring and interventions.Aug 15, 2026Mathematical Biomarkers From First-Cycle PSA Dynamics May Predict Adaptive Therapy Outcomes in Prostate CancerA retrospective modeling study of 53 prostate cancer patients found that mechanism-based biomarkers derived from first-cycle PSA dynamics predicted time to progression and survival under adaptive therapy, outperforming standard PSA metrics. The approach could support personalized treatment scheduling.Aug 8, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Predictive Mathematical Biomarkers Transform Personalized Adaptive Therapy in Prostate Cancer
Mathematical biomarkers derived from initial PSA dynamics effectively predict adaptive therapy outcomes in prostate cancer, enabling personalized treatment strategies that outperform traditional PSA measures.
Aug 8, 2026
MIND Diet Linked to Lower Cancer Risk and Reduced Mortality, With New Genetic InsightsA meta-analysis of 23 observational studies shows higher MIND diet adherence is associated with a 55% lower cancer risk and reduced all-cause and CVD mortality. Separately, the MIND trial now provides genetic data to explore precision nutrition for cognitive decline.Jul 26, 2026
Enhanced Detection of Clinically Significant Prostate Cancer: Insights from the Stockholm3-MRI Screening Study Two-Year Follow-upThe Stockholm3 test combined with MRI screening significantly improves detection of clinically significant prostate cancer compared to PSA alone, reducing missed cases and unnecessary biopsies in a population-based study with 2-year follow-Jun 25, 2026